A Study Comparing PF-06273340 Immediate Release Tablet, PF-06273340 Modified Release Tablets To PF-06273340 Oral Solution In The Fasted State. This Study Will Also Compare PF-06273340 Modified Release Tablets In Fasted And Fed State

NCT01706796 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-06273340
DRUG: PF-06273340
DRUG: PF-06273340
DRUG: PF-06273340
DRUG: PF-06273340
DRUG: PF-06273340

Sponsor

Pfizer